172 related articles for article (PubMed ID: 2169575)
21. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1079-82. PubMed ID: 1981011
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptors in human endocrine tumors.
Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.
Srikant CB; Murthy KK; Patel YC
Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):339-44. PubMed ID: 1312325
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
Fekete M; Wittliff JL; Schally AV
J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):185-8. PubMed ID: 1356013
[TBL] [Abstract][Full Text] [Related]
29. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
[TBL] [Abstract][Full Text] [Related]
30. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
Schaer JC; Waser B; Mengod G; Reubi JC
Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
[TBL] [Abstract][Full Text] [Related]
33. PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion.
Shimon I; Rubinek T; Hadani M; Alhadef N
J Endocrinol Invest; 2004 Sep; 27(8):721-7. PubMed ID: 15636423
[TBL] [Abstract][Full Text] [Related]
34. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
Reubi JC; Schaer JC; Laissue JA; Waser B
Metabolism; 1996 Aug; 45(8 Suppl 1):39-41. PubMed ID: 8769377
[TBL] [Abstract][Full Text] [Related]
36. Expression of somatostatin receptors in peritumoral veins of human tumors.
Denzler B; Reubi JC
Cancer; 1999 Jan; 85(1):188-98. PubMed ID: 9921992
[TBL] [Abstract][Full Text] [Related]
37. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
[TBL] [Abstract][Full Text] [Related]
38. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Metabolism; 1992 Sep; 41(9 Suppl 2):111-5. PubMed ID: 1355584
[TBL] [Abstract][Full Text] [Related]
39. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.
Ferone D; van Hagen PM; van Koetsveld PM; Zuijderwijk J; Mooy DM; Lichtenauer-Kaligis EG; Colao A; Bogers AJ; Lombardi G; Lamberts SW; Hofland LJ
Endocrinology; 1999 Jan; 140(1):373-80. PubMed ID: 9886848
[TBL] [Abstract][Full Text] [Related]
40. A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment.
Polak M; Bertherat J; Li JY; Kujas M; Le Dafniet M; Weizani H; Van Effenterre R; Epelbaum J; Turpin G
Acta Endocrinol (Copenh); 1991 Apr; 124(4):479-86. PubMed ID: 1851593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
